AGNPF (Grey Matters Health) Research & Development: $0.04 Mil (TTM As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGNPF Grey Matters Health Inc AGNPF
26 GF Score
Price $0.31
! 1 Warning Sign
View Full Analysis

What is Grey Matters Health Research & Development?

Grey Matters Health AGNPF +12.74% 26 Research & Development is $0.04 Mil as of May. 2026. GuruFocus rates AGNPF with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Grey Matters Health's Research & Development for the three months ended in May. 2026 was $0.02 Mil. Its Research & Development for the trailing twelve months (TTM) ended in May. 2026 was $0.04 Mil.

Grey Matters Health  (OTCPK:AGNPF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Grey Matters Health Research & Development Related Terms

Grey Matters Health Research & Development Historical Data

* Premium members only.

The historical data trend for Grey Matters Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Matters Health Research & Development Chart

Grey Matters Health Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.81 1.78 0.81 0.48 0.06

Grey Matters Health Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.00 0.02
AGNPF
26GF Score
Grey Matters Health Inc AGNPF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Matters Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in May. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.04 Mil mean?
Grey Matters Health (AGNPF) has a Research & Development of $0.04 Mil as of May. 2026. Research and development expense is the total cost for research and development activities. View historical data on Grey Matters Health and its competitors.
Is Grey Matters Health's Research & Development too high?
Grey Matters Health's current Research & Development is $0.04 Mil. Overall, Grey Matters Health has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Grey Matters Health's Research & Development compare to VRTX and REGN?
Grey Matters Health's Research & Development of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Grey Matters Health and its competitors. Grey Matters Health's current Research & Development is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Matters Health stock overvalued right now?
Grey Matters Health (AGNPF) has a current Research & Development of $0.04 Mil. The current Research & Development is $0.04 Mil. Grey Matters Health's overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Grey Matters Health (AGNPF), the current Research & Development is $0.04 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grey Matters Health Business Description

Other Exchanges GREY:Canada
Address 601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2
Grey Matters Health Inc is a drug repurposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations, and seeking new regulatory approvals in world-wide markets.
26GF Score

Get the complete analysis for AGNPF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price